These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31650904)

  • 21. Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults.
    Mathers Dunbar L; Hassman J; Tellier G
    Clin Ther; 2004 Jan; 26(1):48-62. PubMed ID: 14996517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
    Herath SC; Poole P
    Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of community-acquired pneumonia with moxifloxacin: a meta-analysis of randomized controlled trials.
    Yuan X; Liang BB; Wang R; Liu YN; Sun CG; Cai Y; Yu XH; Bai N; Zhao TM; Cui JC; Chen LA
    J Chemother; 2012 Oct; 24(5):257-67. PubMed ID: 23182045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A controlled, double-blind, multicenter study comparing clarithromycin extended-release tablets and levofloxacin tablets in the treatment of community-acquired pneumonia.
    Gotfried MH; Dattani D; Riffer E; Devcich KJ; Busman TA; Notario GF; Palmer RN
    Clin Ther; 2002 May; 24(5):736-51. PubMed ID: 12075942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative efficacy and safety study of clarithromycin, roxithromycin and erythromycin stearate in mild pneumonia.
    Hatipoglu ON; Tasan Y
    Yonsei Med J; 2000 Jun; 41(3):340-4. PubMed ID: 10957888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
    Bradley JS; Arguedas A; Blumer JL; Sáez-Llorens X; Melkote R; Noel GJ
    Pediatr Infect Dis J; 2007 Oct; 26(10):868-78. PubMed ID: 17901791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotics for whooping cough (pertussis).
    Altunaiji S; Kukuruzovic R; Curtis N; Massie J
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004404. PubMed ID: 15674946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia.
    Dresser LD; Niederman MS; Paladino JA
    Chest; 2001 May; 119(5):1439-48. PubMed ID: 11348951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival benefit associated with clarithromycin in severe community-acquired pneumonia: A matched comparator study.
    Kyriazopoulou E; Sinapidis D; Halvatzis S; Velissaris D; Alexiou N; Kosmas V; Adami ME; Kyprianou M; Kyprianou A; Stefos A; Lada M; Koutoukas P; Pavlaki M; Kyriakoudi A; Makina A; Gogos C; Niederman MS; Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2020 Jan; 55(1):105836. PubMed ID: 31704213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An open, randomized, comparative study of clarithromycin and erythromycin in the treatment of children with community-acquired pneumonia.
    Lee PI; Wu MH; Huang LM; Chen JM; Lee CY
    J Microbiol Immunol Infect; 2008 Feb; 41(1):54-61. PubMed ID: 18327427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community-acquired pneumonia.
    Anderson G; Esmonde TS; Coles S; Macklin J; Carnegie C
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():117-24. PubMed ID: 1827098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and Safety of Adjunctive Corticosteroids Therapy for Severe Community-Acquired Pneumonia in Adults: An Updated Systematic Review and Meta-Analysis.
    Bi J; Yang J; Wang Y; Yao C; Mei J; Liu Y; Cao J; Lu Y
    PLoS One; 2016; 11(11):e0165942. PubMed ID: 27846240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical efficacy of oral clarithromycin monotherapy in patients with mild or moderate community-acquired pneumonia].
    Fujiki R; Rikimaru T; Aizawa H; Kawayama T
    Jpn J Antibiot; 2003 Dec; 56(6):712-8. PubMed ID: 15007880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corticosteroids for pneumonia.
    Stern A; Skalsky K; Avni T; Carrara E; Leibovici L; Paul M
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD007720. PubMed ID: 29236286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized, multicentre study of the efficacy and tolerance of azithromycin versus clarithromycin in the treatment of adults with mild to moderate community-acquired pneumonia. Azithromycin Study Group.
    O'Doherty B; Muller O
    Eur J Clin Microbiol Infect Dis; 1998 Dec; 17(12):828-33. PubMed ID: 10052544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoroquinolones or macrolides in combination with β-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis.
    Vardakas KZ; Trigkidis KK; Falagas ME
    Clin Microbiol Infect; 2017 Apr; 23(4):234-241. PubMed ID: 27965070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild-to-moderate community-acquired pneumonia in adults.
    Drehobl MA; De Salvo MC; Lewis DE; Breen JD
    Chest; 2005 Oct; 128(4):2230-7. PubMed ID: 16236879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ceftriaxone combination therapy versus respiratory fluoroquinolone monotherapy for community-acquired pneumonia: A meta-analysis.
    Zhang YQ; Zou SL; Zhao H; Zhang MM; Han CL
    Am J Emerg Med; 2018 Oct; 36(10):1759-1765. PubMed ID: 29499898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacoeconomic analysis of community-acquired pneumonia treatment with telithromycin or clarithromycin].
    Rubio-Terrés C; Cots JM; Domínguez-Gil A; Herreras A; Sánchez Gascón F; Chang J; Trilla A
    Rev Esp Quimioter; 2003 Sep; 16(3):295-303. PubMed ID: 14702121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.